Time to Let the Air Out
If you think biotech stocks are headed for a breakout anytime soon, allow us to burst your bubble
FDA rules need tweaking
The biotech industry is suffering a mini-crisis of confidence that mirrors the larger shocks that have sent Wall Street reeling.
A new map of the human genome should help both doctors and biologists
Will R&D Make Merck Hot Again?
The drug giant gets out of the prescription business and bets it all on science.
Cracking the cancer code
Whether a tumor invades the lung or breast is beside the point. Its genetic activity will dictate how to attack it